Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Carvana Co (CVNA) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance

Carvana CoTrade
Recursion Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Carvana Co vs Recursion Pharmaceuticals Inc — how do they compare? Carvana Co trades at $71.97 (market cap $79.17B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Carvana Co is far larger — about 43.7× Recursion Pharmaceuticals Inc's market cap, and Carvana Co is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

CVNARXRX
Market Cap
$79.17B$1.81B
Sector
Consumer CyclicalHealth
52-Week High
$95.69$6.79
52-Week Low
$56.27$2.84
Enterprise Value
$81.65B$1.33B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Carvana Co

Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage.

Read more on CVNA

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Read more on RXRX